Wells Fargo’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
SI
LGM
AAA
O
CCC
TCM
LFCM
Wells Fargo's NXTC Position: Q2 2024 in Review
Wells Fargo sold out of NextCure (NXTC) in Q2 2024, closing a stake of 180 shares — an estimated $4.81K sold.
Wells Fargo first reported a position in NXTC in Q2 2019 and held it in 19 quarters. The position peaked at $1.21M in Q2 2020. 48 funds tracked by Wall St. Rank hold NXTC as of Q2 2024.
- Wells Fargo reported no remaining NextCure position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 180 NextCure shares in Q2 2024, an estimated $4.81K.
- Wells Fargo first reported a position in NextCure in Q2 2019 and held it in 19 quarters.
- Wells Fargo's NextCure position peaked at $1.21M in Q2 2020.
- 48 funds tracked by Wall St. Rank held NextCure as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.